21st Feb 2008 16:27
EiRx Therapeutics PLC21 February 2008 TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer ofexisting shares to which voting rights are attached: Eirx Therapeutics Plc 2. Reason for notification (yes/no) An acquisition or disposal of voting rights YES An acquisition or disposal of financial instruments which may result in theacquisition of shares already issued to which voting rights are attached NO An event changing the breakdown of voting rights NO Other (please specify):______________ NO 3. Full name of person(s) subject to notification obligation: Barclays PLC 4. Full name of shareholder(s) (if different from 3): Barclays Stockbrokers Ltd 5. Date of transaction (and date on which the threshold is crossed or reached if different): 19 February 2008 6. Date on which issuer notified: 20 February 2008 7. Threshold(s) that is/are crossed or reached: 6% to 7% 8. Notified details: N/A A: Voting rights attached to shares Class/type of Situation previous to the Resulting situation after the triggering transactionshares triggering transaction Number of Number of Number of Number of voting rights Percentage of votingIf possible use shares voting shares rightsISIN code rights Direct Direct Indirect Direct Indirect GB00B0XQBS97 187,968,924 187,968,924 211,630,528 0 211,630,528 0.00 7.11 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of votinginstrument period/date that may be acquired rights (if the instrument exercised/converted) N/A N/A N/A N/A N/A Total (A+B)Number of voting rights Percentage of voting rights 211,630,528 7.11 9. Chain of controlled undertakings through which the voting rights and /or thefinancial instruments are effectively held, if applicable: Barclays Stockbrokers Ltd Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease N/Ato hold: 12. Date on which proxy holder will cease to hold N/Avoting rights: 13. Additional information: N/A 14 Contact name: Geoff Smith 15. Contact telephone name: 0207 116 2913 For notes on how to complete form TR-1 please see the FSA website. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Barclays